211 related articles for article (PubMed ID: 23512990)
21. Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy.
Moc C; Taylor AE; Chesini GP; Zambrano CM; Barlow MS; Zhang X; Gustafsson ÅB; Purcell NH
Cardiovasc Res; 2015 Feb; 105(2):160-70. PubMed ID: 25411382
[TBL] [Abstract][Full Text] [Related]
22. Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL.
Rajala RV; Kanan Y; Anderson RE
Adv Exp Med Biol; 2016; 854():419-24. PubMed ID: 26427440
[TBL] [Abstract][Full Text] [Related]
23. Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells.
Patterson SJ; Han JM; Garcia R; Assi K; Gao T; O'Neill A; Newton AC; Levings MK
J Immunol; 2011 May; 186(10):5533-7. PubMed ID: 21498666
[TBL] [Abstract][Full Text] [Related]
24. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.
Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608
[TBL] [Abstract][Full Text] [Related]
25. Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation.
Bradley EW; Carpio LR; Newton AC; Westendorf JJ
J Biol Chem; 2015 Jun; 290(26):16272-80. PubMed ID: 25953896
[TBL] [Abstract][Full Text] [Related]
26. δ-Tocopherol inhibits receptor tyrosine kinase-induced AKT activation in prostate cancer cells.
Wang H; Hong J; Yang CS
Mol Carcinog; 2016 Nov; 55(11):1728-1738. PubMed ID: 26465359
[TBL] [Abstract][Full Text] [Related]
27. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
[TBL] [Abstract][Full Text] [Related]
28. The phosphatase PHLPP controls the cellular levels of protein kinase C.
Gao T; Brognard J; Newton AC
J Biol Chem; 2008 Mar; 283(10):6300-11. PubMed ID: 18162466
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-alpha upregulated PHLPP1 through activating nuclear factor-kappa B during myocardial ischemia/reperfusion.
Tang B; Ma J; Ha X; Zhang Y; Xing Y
Life Sci; 2018 Aug; 207():355-363. PubMed ID: 29940243
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.
Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM
J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368
[TBL] [Abstract][Full Text] [Related]
31. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.
Brognard J; Sierecki E; Gao T; Newton AC
Mol Cell; 2007 Mar; 25(6):917-31. PubMed ID: 17386267
[TBL] [Abstract][Full Text] [Related]
32. PHLPP Signaling in Immune Cells.
Lordén G; Lam AJ; Levings MK; Newton AC
Curr Top Microbiol Immunol; 2022; 436():117-143. PubMed ID: 36243842
[TBL] [Abstract][Full Text] [Related]
33. Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression.
Huang YS; Chang CC; Lee SS; Jou YS; Shih HM
Oncotarget; 2016 Jul; 7(28):43256-43266. PubMed ID: 27248326
[TBL] [Abstract][Full Text] [Related]
34. PHLPPing through history: a decade in the life of PHLPP phosphatases.
Grzechnik AT; Newton AC
Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase 3 suppression increases PH domain and leucine-rich repeat phosphatase (Phlpp)1 expression in chondrocytes to suppress Akt signaling and matrix secretion.
Bradley EW; Carpio LR; Westendorf JJ
J Biol Chem; 2013 Apr; 288(14):9572-9582. PubMed ID: 23408427
[TBL] [Abstract][Full Text] [Related]
36. PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation.
Yu Y; Dai M; Lu A; Yu E; Merlino G
Oncogene; 2018 Apr; 37(17):2225-2236. PubMed ID: 29391600
[TBL] [Abstract][Full Text] [Related]
37. miR-190 promotes HCC proliferation and metastasis by targeting PHLPP1.
Xiong Y; Wu S; Yu H; Wu J; Wang Y; Li H; Huang H; Zhang H
Exp Cell Res; 2018 Oct; 371(1):185-195. PubMed ID: 30092222
[TBL] [Abstract][Full Text] [Related]
38. SKP2 Contributes to AKT Activation by Ubiquitination Degradation of PHLPP1, Impedes Autophagy, and Facilitates the Survival of Thyroid Carcinoma.
Shao Y; Ren W; Dai H; Yang F; Li X; Zhang S; Liu J; Yao X; Zhao Q; Sun X; Zheng Z; Xu C
Mol Cells; 2023 Jun; 46(6):360-373. PubMed ID: 36694914
[TBL] [Abstract][Full Text] [Related]
39. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.
Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669
[TBL] [Abstract][Full Text] [Related]
40. Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes.
Chen CS; Weng SC; Tseng PH; Lin HP; Chen CS
J Biol Chem; 2005 Nov; 280(46):38879-87. PubMed ID: 16186112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
